Sickle Cell Foundation of Tennessee Company Profile

17:42 EDT 18th September 2018 | BioPortfolio

“Our mission is to provide social services, including health, education and life skills, to enhance the quality of life and self-sufficiency of individuals living with Sickle Cell,” said Thompson. “Everything we plan builds our capacity and extends our reach to serve more people. We must grow because there are people in pain who need our help.”

News Articles [1953 Associated News Articles listed on BioPortfolio]

Funding sought to test medical cannabis for sickle cell disease

The Sickle Cell Foundation of Georgia, Biotech Research Laboratories and the Phoenix Tears Foundation aim to raise $250,000 t -More- 

GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Research’s 12th Annual Symposium

SOUTH SAN FRANCISCO, Calif., June 08, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that four abstracts related to the voxelotor program in sickle cell...

A Glance At Potential Therapies For Sickle Cell Disease

Sickle cell disease, or SCD in short, refers to a group of inherited red blood cell disorders. In these patients, the hemoglobin protein present inside the red blood cells is abnormal, causing the RBC...

Foundation awards grant to C-Path consortium to research sickle cell anemia

Doris Duke Charitable Foundation awarded a grant to C-Path to form a consortium to accelerate research developments in sickle cell anemia.

STAT Plus: A much-needed sickle cell drug reaches a critical readout. Here’s what you need to know

People with sickle cell disease have few effective treatment options. A new and novel medicine from a small biotech could soon fill that sickle cell treatment gap.

AHA: New Insights Into Sickle Cell and Stroke Risk

TUESDAY, June 19, 2018 (American Heart Association) -- Sickle cell disease increases the risk of stroke for African Americans -- but recent research shows carrying the genetic trait for sickle cell do...

L-Glutamine Benefit Patients With Sickle Cell Disease

For people with sickle cell disease, oral twice-daily L-glutamine reduces hospitalization and trims the number of sickle cell crises compared with placebo, whether or not they are also receiving hydro...

New transplant protocol allows treatment of sickle cell disease

Doctors at the University of Illinois Hospital have successfully treated seven sickle cell disease patients using stem cells from donors...Read More... The post New transplant protocol allows treatmen...

Drugs and Medications [494 Associated Drugs and Medications listed on BioPortfolio]

Esika [Ventura Corporation (San Juan, P.R)]

ēsika 3-in-1 Pro Make Up Foundation SPF 20

Sheer cover mineral foundation [Guthy-Renker LLC]

Sheer Cover Mineral Foundation SPF-15

Cle de peau beaute silky foundation i [SHISEIDO CO., LTD.]

CPB Silky Cream Foundation I

Cle de peau beaute foundation i [SHISEIDO CO., LTD.]

cle de peau BEAUTE Cream Foundation I

Shiseido perfect refining foundation [SHISEIDO AMERICA INC.]

SHISEIDO Perfect Refining Foundation

PubMed Articles [2966 Associated PubMed Articles listed on BioPortfolio]

A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

Oxidative stress contributes to the complex pathophysiology of sickle cell disease. Oral therapy with pharmaceutical-grade l-glutamine (USAN, glutamine) has been shown to increase the proportion of th...

Rheological properties of sickle erythrocytes in patients with sickle cell anaemia: the effect of hydroxyurea, fetal hemoglobin and α-thalassaemia.

Determine the effect of foetal haemoglobin (HbF) and α-thalassaemia on red blood cell (RBC) deformability of patients with sickle cell anaemia (SCA) with and without hydroxyurea (HU).

Intra-operative cell salvage and sickle cell trait in liver transplantation: time to re-consider?

Sickle cell trait (SCT), characterized by the sickle hemoglobin (HbS) gene in a heterozygous state is the most common hemoglobinopathy worldwide that is typically asymptomatic in affected individuals ...

Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula.

To identify systemic risk factors for sickle cell maculopathy, and to analyze the microstructure of the macula of Sickle Cell Disease (SCD) patients by using automated segmentation of individual retin...

Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children.

The phenotypic expression of sickle cell disease (SCD) is a complex pathophysiologic condition. However, sickle erythrocytes might be the cause for multiple sources of pro-oxidant processes with conse...

Clinical Trials [6505 Associated Clinical Trials listed on BioPortfolio]

Spectralis HRA+OCT Imaging of the Retina With Autofluorescence in Sickle Cell Disease

To determine the retinal and choroidal thickness in patients with sickle cell disease compared to age, race matched population without sickle cell disease to allow a better understanding o...

Dose-Escalation Study of SCD-101 in Sickle Cell Disease

The purpose of this study is to determine the safety and clinical effects of SCD-101 when given to adults with sickle cell disease. SCD-101 inhibits sickling of red blood cells containing ...

Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell Center

To continue studies on the two major neurological complications of sickle cell disease (SCD): namely, stroke and chronic encephalopathy.

A Study of IMR-687 in Adult Patients With Sickle Cell Anaemia (Homozygous HbSS or Sickle-β0 Thalassemia)

A Phase 2a randomized, placebo-controlled, multicenter study of orally administered IMR-687 in adults with Sickle Cell Anaemia (SCA).

Multi-center Study of SC411 for Sickle Cell Disease

The purpose of this study is to determine whether treatment of sickle cell patients with docosahexaenoic omega-3 acid (DHA) is effective in prevention of acute sickle cell crisis.

Companies [2522 Associated Companies listed on BioPortfolio]

Sickle Cell Foundation of Tennessee

“Our mission is to provide social services, including health, education and life skills, to enhance the quality of life and self-sufficiency of individuals living with Sickle...

MP&F Strategic Communications and BlueCross BlueShield of Tennessee

The BlueCross BlueShield of Tennessee Health Foundation, Inc., was established in December 2003 as a 501(c)(3) not-for-profit corporation organized to promote the philanthropic mi...

BlueCross BlueShield of Tennessee Health Foundation, Inc.

The BlueCross BlueShield of Tennessee Health Foundation, Inc. (THF) was established in December, 2003 as a 501(c)(3) not-for-profit corporation organized to promote the philanthro...

Imara Inc.

Imara Inc., a Cydan Development company, is dedicated to developing novel therapeutics for patients with sickle cell disease. Imara is developing IMR-687, a highly s...

The William E. Proudford Sickle Cell Fund

More Information about "Sickle Cell Foundation of Tennessee" on BioPortfolio

We have published hundreds of Sickle Cell Foundation of Tennessee news stories on BioPortfolio along with dozens of Sickle Cell Foundation of Tennessee Clinical Trials and PubMed Articles about Sickle Cell Foundation of Tennessee for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sickle Cell Foundation of Tennessee Companies in our database. You can also find out about relevant Sickle Cell Foundation of Tennessee Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Corporate Database Quicklinks

Searches Linking to this Company Record